Mayzent® (Siponimod) approved in Europe

The European Commission has approved oral siponimod for the treatment of adults with active secondary progressive MS

Read more

Join the Alliance

The Alliance now includes 18 MS organisations, all working together to speed up treatments for progressive MS

Read more

Sign up to our e-newsletter
for updates from our growing global initiative to end progressive MS

Clicking submit confirms that you consent to MSIF sending you the Progressive MS Alliance newsletter

Please note, you must be aged 18 or older to subscribe to our newsletters.

Click here to read our Terms & Conditions and Privacy Policy

Progressive MS Alliance members

  • MS International Federation logo
  • MS Research Australia logo
  • Nationale Belgische Multiple Sclerosa Liga logo
  • Logo with the words Multiple Sclerosis Society of Canada
  • Logo with the Danish words Sclerose foreningen
  • Fondation pour l’Aide à la Recherche sur la Sclérose En Plaques logo
  • Ligue Française contre la Sclérose En Plaques logo
  • Logo with the words (in Italian) Associazione Italiana Sclerosi Multipla
  • Stichting MS Research logo
  • Logo with the words (in Spanish) Esclerosis Múltiple España (Spain)
  • National MS Society (USA) logo